Inserm Transfert Initiative

Inserm Transfert Initiative

Inserm Transfert Initiative

Suggest edits
Follow us
Also headquartered in Paris
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 7

Portfolio

Portfolio Tracker

Add info
FinSMEs

Pfizer Acquires Clinical-Stage Biotech Company Therachon, for Up To $810M

Pfizer
Pfizer
Therachon
Therachon
$60,000,000 Venture capital (Series B)
FinSMEs

Biotech Company Therachon Raises $60M Mezzanine Financing

Funding Health
Therachon AG
Therachon AG
Therachon
Therachon
$15,000,000 Venture capital (Series A)
FinSMEs

Biomodex Raises $15M in Series A Funding

Funding
BIOMODEX
BIOMODEX
£40,000,000 Venture capital (Series B)
PE HUB , FinSMEs

ENYO Pharma raises 40 mln pounds

Funding Health Science
ENYO Pharma
ENYO Pharma

Biomodex, 12 millions d’euros pour mettre l’impression 3D au service des chirurgiens

BIOMODEX
BIOMODEX
$5,000,000 Venture capital (Series A)
Therachon

Therachon Appoints Luca Santarelli, M.D., as Chief Executive Officer and Extends Series A Financing

Therachon
Therachon
€22,000,000 Venture capital (Series A)
FinSMEs

Enyo Pharma Secures €22M Series A Financing

Health Funding
ENYO Pharma
ENYO Pharma
$35,000,000 Venture capital (Series A)
businesswire

Therachon Secures $35 Million Financing | Business Wire